Gamma Gliadin IgG

If you cut out gluten and felt better, or celiac disease runs in your family, you may wonder whether your immune system is truly reacting to wheat. This test looks for one specific antibody your body can produce against a wheat gluten protein.

Here is the part most people never hear: this particular antibody is not the test doctors rely on to diagnose celiac disease, and a positive result on its own does not confirm you have it. It is best treated as an exploratory clue, not an answer.

What This Antibody Actually Is

Gamma gliadin IgG (an immunoglobulin G antibody against the gamma-gliadin proteins in wheat) is one of the proteins your immune system builds to tag substances it reacts to. Gliadin is one of the two main protein fractions of wheat gluten (the other is glutenin), and gamma-gliadin is one of its subgroups.

The test measures the concentration of this antibody in your blood. It does not measure gluten itself or any intestinal damage. A raised level reflects that your immune system has been exposed to gluten and mounted a response against it, produced by the antibody-making cells of your immune system.

Native Versus Deamidated: Why the Version Matters

There are two very different tests that both get called "gliadin IgG," and they are not interchangeable. The older, native version measures antibodies against the whole, unmodified gliadin protein. A newer version measures antibodies against a chemically altered fragment (called deamidated gliadin peptides), and it performs noticeably better.

This distinction matters for how much weight to give your result. In one study of 216 people, the older native gliadin IgG caught only about 42 out of 100 celiac cases, while the deamidated version caught about 65, and the standard tissue transglutaminase test caught about 78. If your result comes from a native gamma-gliadin assay, treat it as the least precise of the gluten antibody tests.

Celiac Disease

The strongest disease link is celiac disease, a gluten-triggered immune reaction that damages the lining of the small intestine in genetically susceptible people. People with celiac disease do carry much higher gliadin antibody levels than healthy people, so a high result raises suspicion.

The problem is specificity. In one study of apparently healthy blood donors, an isolated positive anti-gliadin IgG had a positive predictive value of 0 percent, meaning it flagged people who did not actually have the disease. The exact figure comes from a single small sample, but the broader point holds: isolated anti-gliadin IgG performs poorly in healthy populations. This is why guidelines put tissue transglutaminase IgA plus total IgA first, and treat gliadin IgG as a supporting clue at best.

Why a Positive Result Does Not Mean You Have a Disease

Roughly 10 percent of the general population carries anti-gliadin antibodies, and in a case-control study these incidental antibodies were not linked to any cognitive, quality-of-life, or brain-imaging problems. So a positive result is common and often harmless.

The way to hold both facts together is this: gamma gliadin IgG is not a simple good-number, bad-number switch. It is a marker of immune exposure to gluten. A high level can occur without disease, and a low or negative level does not clear you, because some people have celiac disease with negative standard antibodies. That seronegative form actually carries a higher risk of complications, about 11 times higher, and roughly double the mortality compared with the antibody-positive form, which is why a normal antibody result should never be the final word if symptoms persist.

When an IgG-Based Test Genuinely Helps

There is one setting where an IgG-based gliadin test earns its place. People who are deficient in IgA, the antibody class used in the standard celiac tests, can get falsely negative results on those tests. In IgA-deficient people with celiac disease, IgG antibodies against deamidated gliadin reached about 88 percent sensitivity, close to the IgG transglutaminase test. If you have low or absent IgA, an IgG-based gluten test is the appropriate second step.

Brain and Psychiatric Associations

Elevated gliadin IgG shows up in some conditions outside the gut, but this evidence is early and exploratory. Roughly a third of people with schizophrenia and related disorders carry high anti-gliadin IgG (studies report positivity rates spanning about a quarter to a third), marking a subgroup with more inflammatory features. In one study, mothers whose anti-gliadin IgG sat above the 90th percentile had offspring with about 1.7 times the odds of developing a nonaffective psychosis.

These findings describe patterns in specific groups, not a diagnostic use. The immune reaction to gluten in schizophrenia appears to target different protein regions than in celiac disease, so a positive result here is not the same signal. Treat any brain-related interpretation as a research signal rather than a personal conclusion.

This Is Not a Wheat Allergy Test

A common mix-up is worth heading off. Classic wheat allergy, the kind that causes hives or anaphylaxis, is driven by a different antibody class called IgE. Gamma-gliadin is in fact a major wheat allergen, but the relevant test for allergy is gamma gliadin IgE, not IgG. If your concern is a rapid allergic reaction to wheat, IgG testing is the wrong tool and IgE-based testing is what applies.

Non-Celiac Gluten Sensitivity

Many people who feel worse on gluten but do not have celiac disease hope this antibody will confirm a gluten sensitivity. It cannot. There is no validated blood biomarker for non-celiac gluten sensitivity, and diagnosis still rests on symptoms and a supervised gluten challenge. A positive gamma gliadin IgG is consistent with gluten reactivity but does not prove this condition.

Why One Reading Tells You Little

This antibody rises and falls with how much gluten you eat. You must be eating gluten regularly for the result to mean anything, because a gluten-free diet lowers the level and can produce a falsely reassuring reading. That dependence on diet is exactly why a single snapshot is weak. If you are being evaluated after already reducing gluten, guidelines describe a formal gluten challenge, historically about 10 grams of gluten a day for at least 8 weeks, though newer data suggest smaller amounts over shorter periods may suffice, always done under medical supervision.

The more useful approach is to track the trajectory. Get a baseline while still eating gluten, then, if you make a dietary change under medical guidance, retest in 3 to 6 months to see whether the level is falling, and at least annually after that. Keep in mind that the clearest evidence that these antibodies decline on a gluten-free diet comes from the deamidated gliadin test, a related but better-studied measurement, so read a native gamma-gliadin trend with that caveat.

What to Do With an Unexpected Result

A positive gamma gliadin IgG should trigger a proper workup, not a conclusion. The next step is tissue transglutaminase IgA plus total IgA, the guideline-preferred first-line pair, and often the deamidated gliadin IgG version for comparison. Do not start a gluten-free diet before this workup, because removing gluten lowers the antibodies and can mask celiac disease on every subsequent test.

How the findings combine is what matters. A positive transglutaminase IgA with symptoms warrants referral to a gastroenterologist and usually a duodenal biopsy to confirm intestinal damage. An isolated gliadin IgG with a normal transglutaminase test is usually low yield, unless you are IgA-deficient, in which case the IgG result carries real weight and deserves specialist input.

When Results Can Be Misleading

• Already gluten-free: if you have reduced or removed gluten before testing, your level can read falsely low, because the antibody depends on ongoing gluten exposure to form.
• Incidental positivity: roughly 10 percent of healthy people carry these antibodies without any disease, so a mildly positive result in someone with no symptoms often means little.
• IgA deficiency: total IgA status changes how the whole gluten panel should be read, and without knowing it a result can be badly misinterpreted.
• Assay variability: the older native gliadin test is not standardized across labs, so numbers from different labs are not directly comparable.